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Mto2 multisite phosphorylation inactivates
non-spindle microtubule nucleation complexes
during mitosis
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Juri Rappsilber1,2 & Kenneth E. Sawin1
Microtubule nucleation is highly regulated during the eukaryotic cell cycle, but the
underlying molecular mechanisms are largely unknown. During mitosis in ﬁssion yeast
Schizosaccharomyces pombe, cytoplasmic microtubule nucleation ceases simultaneously with
intranuclear mitotic spindle assembly. Cytoplasmic nucleation depends on the Mto1/2
complex, which binds and activates the g-tubulin complex and also recruits the g-tubulin
complex to both centrosomal (spindle pole body) and non-centrosomal sites. Here we show
that the Mto1/2 complex disassembles during mitosis, coincident with hyperphosphorylation
of Mto2 protein. By mapping and mutating multiple Mto2 phosphorylation sites, we generate
mto2-phosphomutant strains with enhanced Mto1/2 complex stability, interaction with
the g-tubulin complex and microtubule nucleation activity. A mutant with 24 phosphorylation
sites mutated to alanine, mto2[24A], retains interphase-like behaviour even in mitotic cells.
This provides a molecular-level understanding of how phosphorylation ‘switches off’ micro-
tubule nucleation complexes during the cell cycle and, more broadly, illuminates mechanisms
regulating non-centrosomal microtubule nucleation.
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T
he microtubule (MT) cytoskeleton undergoes dramatic
rearrangements during eukaryotic cell cycle progression
and cell differentiation1. For example, as cells enter mitosis
to form a mitotic spindle, MT nucleation from the centrosome
increases several-fold2. The major regulator of MT nucleation
in vivo is the g-tubulin complex (g-TuC; in higher eukaryotes,
also called g-tubulin ring complex, or g-TuRC)1,3–6, and thus
understanding the regulation of g-TuC-dependent MT nucleation
is critical to understanding MT organization from a mechanistic
perspective.
In the case of the mitotic spindle, increased centrosomal MT
nucleation upon mitotic onset is associated with increased
centrosomal recruitment of the g-TuC2,7,8. Several, possibly
redundant, mechanisms have been suggested to contribute to cell
cycle regulation of g-TuC localization, and many of these involve
phosphorylation of structural proteins within the centrosome by
cell cycle-dependent protein kinases such as CDK1, Plk1 and
Aurora A (reviewed in ref. 1). By contrast, cell cycle regulation
of g-TuC activity is less well understood, although recent
advances in budding yeast indicate a role for cell cycle-
dependent phosphorylation of Spc110p, a homolog of the
human centrosomal protein pericentrin, in promoting mitotic
spindle MT nucleation from the yeast spindle pole bodies (SPBs,
yeast centrosome equivalent)9. Spc110p facilitates assembly of
multiple g-tubulin small complexes (g-TuSCs)4 into a multimeric
structure resembling the higher-eukaryotic g-TuRC10–12, and this
depends on phosphorylation of Spc110p by cell cycle kinases
Cdk1p and Mps1p9.
Relative to the mechanisms that activate g-TuC-dependent MT
nucleation, almost nothing is known about complementary
mechanisms that ‘switch off’ nucleation. For example, in
vertebrate cells, the Golgi apparatus is an important non-
centrosomal MT organizing centre (MTOC)13,14, and during
mitosis, Golgi MTOC activity is drastically decreased15, but the
mechanistic basis for this downregulation has not yet been
explored. Mechanisms that switch off MT nucleation may be of
particular importance in cytoskeletal rearrangements that
accompany cell differentiation—including muscle, neuronal and
epithelial cell development16–21. In many of these instances, non-
centrosomal MTOCs (for example, Golgi apparatus, nuclear
envelope (NE), or regions of plasma membrane) can nucleate
MTs alongside, or instead of, the centrosome.
Fission yeast Schizosaccharomyces pombe provides a particu-
larly appropriate model system for understanding regulation of
MTOCs, because it contains several distinct types of MTOCs,
both centrosomal and non-centrosomal, and these vary during
the cell cycle22 (Fig. 1a). During interphase, MTs are nucleated in
the cytoplasm from the cytoplasmic face of the SPB, from the NE
and from MTs themselves. Upon mitotic entry, nucleation from
these interphase MTOCs ceases, and the mitotic SPBs become the
only active MTOCs, nucleating intranuclear mitotic spindle MTs
from the nucleoplasmic face of the SPBs. Later in mitosis, astral
MTs are nucleated from the cytoplasmic face of the SPBs23.
Finally, during cytokinesis, MTOCs are redistributed to the
contractile actomyosin ring, to form a post-anaphase array of
MTs24.
Mitotic spindle MT nucleation in ﬁssion yeast depends on the
Spc110p ortholog Pcp1 (refs 25,26), which is localized to the
nucleoplasmic face of the SPB and may be regulated similarly to
Spc110p9.
Interphase cytoplasmic MT nucleation in ﬁssion yeast, on
the other hand, depends on the Mto1/2 complex, which is
composed of multiple copies of the interacting proteins Mto1 and
Mto2 (refs 27–32). Multimeric Mto1/2 interacts with several
copies of the g-TuSC to generate g-TuRC-like MT-nucleation
complexes in vivo32. Mto1, like Pcp1 and Spc110p, contains a
Centrosomin Motif 1 region near its N-terminus, and this is
required for interaction with the g-TuC33. Centrosomin Motif 1
regions are conserved in proteins involved in MT nucleation from
yeast to human, and all of these appear to be speciﬁcally involved
in regulation of the g-TuC9,28,34–36.
The Mto1/2 complex itself is dynamically distributed among
multiple sites during the cell cycle24,27–31 (see Fig. 1a for
overview). During interphase, Mto1/2 localizes to SPBs and
also, in the form of puncta, to interphase cytoplasmic MTs and, to
a lesser extent, to the NE. During mitosis, Mto1/2 localizes to
SPBs and, during later stages of division, to the contractile
actomyosin ring. Mto1/2 localization to these sites is independent
of interaction with the g-TuC33, and thus by binding to and
recruiting the g-TuC to these sites, Mto1/2 determines the
distribution of all cytoplasmic MTOC sites in the cell.
As in higher eukaryotes, relatively little is known about the
molecular mechanisms that modulate MTOCs and the g-TuC
during the ﬁssion yeast cell cycle. In particular, much remains to
be learned about how interphase cytoplasmic MT nucleation
ceases as cells enter mitosis. Here we address this question
through a combination of microscopy, biochemistry and genetics
approaches. We show that Mto2 is phosphorylated on multiple
sites in vivo, and that mitotic hyperphosphorylation of Mto2
drives disassembly of the Mto1/2 complex, leading to disruption
of interaction with the g-TuC. As part of this study, we used
SILAC (stable isotope labelling of amino acids in culture)
quantitative proteomics37,38 to screen for candidate mitosis-
speciﬁc Mto2 phosphorylation sites, but in an indirect way,
involving quantiﬁcation of non-phosphorylated Mto2 peptides in
mitotic versus interphase cells39,40. Overall, we ﬁnd that
simultaneous mutation of a large number of Mto2
phosphorylation sites to non-phosphorylatable alanine is
necessary to abrogate mitotic disassembly of the Mto1/2
complex. To our knowledge, this provides the ﬁrst molecular-
level understanding of how interphase MT nucleation complexes
are inactivated during the cell cycle and, more generally,
illuminates mechanisms that regulate MT nucleation by non-
centrosomal MTOCs.
Results
Mto1/2 complexes disassemble during mitosis. A conserved
region close to the Mto1 C-terminus is both necessary and suf-
ﬁcient for localization to the SPB, as well as to the contractile
actomyosin ring during cell division, while a nearby, less well-
deﬁned region within the Mto1 C-terminus is required for loca-
lization to MTs24. Recently, we described a truncated form of
Mto1, ‘Mto1[NE]’, in which the entire C-terminal half of Mto1 is
deleted (that is, amino acids 550–1,115, which comprise all
C-terminal localization regions)32. In mto1[NE] cells, puncta of
the resulting Mto1/2 complex, ‘Mto1/2[NE]’, become strongly
enriched on the interphase NE and promote extensive MT
nucleation from the NE32 (the underlying basis for NE
localization is addressed further in the Discussion).
In experiments expressing Mto2-GFP in mto1[NE] cells, we
observed a marked disappearance of Mto1/2[NE] puncta
during mitosis (Fig. 1b). This was evident even in cells in which
Mto1[NE] and Mto2-GFP were overexpressed (Fig. 1c,d,
Supplementary Movie 1). In these cells, Mto1/2[NE] puncta were
highly enriched on the NE during interphase and recruited
signiﬁcant amounts of the g-TuC to the NE (imaged as g-TuSC
protein Alp4-tdTomato); however, during mitosis, these puncta
also disappeared from the NE, as did the g-TuC (Fig. 1d).
To determine whether the disappearance of Mto1/2[NE]
puncta was due to cell cycle-regulated delocalization of
intact Mto1/2[NE] complex puncta from the NE, or to cell
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cycle-regulated disassembly of the Mto1/2[NE] puncta them-
selves, we imaged Mto2-GFP in a different mto1 mutant,
mto1[bonsai], in which Mto1 is truncated at both the N- and
C-termini32. In mto1[bonsai] mutants, the resulting Mto1/2
complex, ‘Mto1/2[bonsai]’, exists as free cytoplasmic puncta
instead of localizing to the NE, and these puncta nucleate
interphase MTs in a spatially random manner32. Like Mto1/
2[NE] puncta, Mto1/2[bonsai] puncta disappeared during mitosis
(Fig. 1e), suggesting that Mto1/2 complexes undergo cell cycle-
regulated disassembly.
Mto1/2 disassembly coincides with Mto2 hyperphosphorylation.
To investigate this, we arrested cells in mitosis and performed
pulldowns of protein A-tagged Mto1 (Mto1-SZZ) with IgG-beads.
Previous western blot analysis had indicated that Mto2 migrates as
multiple isoforms on SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), suggestive of phosphorylation29,31–33. We
found that Mto2 isoforms from extracts of mitotically
arrested cells migrated signiﬁcantly more slowly than isoforms
from interphase cells (Fig. 2a), suggesting that Mto2 is
hyperphosphorylated during mitosis, and we subsequently
conﬁrmed this using phosphatase treatment and Phos-tag
SDS–PAGE41 (see below). Interestingly, the amount of Mto2
copurifying with Mto1-SZZ was decreased by more than 95% in
extracts from mitotic versus interphase cells (Fig. 2a). (In these
experiments, the very small amount of Mto2 that did copurify with
Mto1-SZZ from mitotic cells was limited to faster-migrating
isoforms, which may have been generated by a small amount of
dephosphorylation during sample processing or, alternatively, were
present at low levels in the original cell extract.) The amount
of g-tubulin copurifying with Mto1-SZZ in extracts from mitotic
a
I
M
MergeMto2-GFP Cut12-tdT
b
Mergenmt81:mto2-GFP mCh-Atb2
c
e
MergeMto2-GFP mCh-Atb2
d
Mergenmt81:Mto2-GFP Alp4-tdT
I
M
I
I
MergeNo tagnmt81:Mto2-GFP
M
Mergenmt81:Mto2-GFP mCh-Atb2
I
mto1[bonsai]
Interph
Anaph
Cytokin
Metaph
nmt81:mto1[NE]nmt81:mto1[NE]
mto1[NE]
Figure 1 | Mto1/2 complex puncta disappear during mitosis. (a) Cartoon summarizing dynamic distribution of Mto1/2 complex during the cell cycle
(interphase, metaphase, anaphase, cytokinesis), with corresponding images of cells expressing Mto2-GFP and mCherry-tubulin (mCh-Atb2). Microtubules
are shown in magenta, spindle pole bodies (SPBs) in yellow and non-SPB microtubule organizing centres containing Mto1/2 complex in green.
(b) Localization of Mto2-GFP in mto1[NE] cells, together with SPB marker Cut12 fused to tandem-dimer Tomato (Cut12-tdT), in interphase (I) and mitosis
(M). Note absence of Mto2-GFP puncta associated with nuclear envelope (NE) during mitosis. (c) Time-lapse images of cell cycle-dependent changes in
localization of Mto2-GFP (mildly overexpressed from nmt81 promoter) in nmt81:mto1[NE] cells, together with mCherry-tubulin (mCh-Atb2). See also
Supplementary Movie 1. Sequence begins in late G2 and continues through mitosis, cytokinesis and separation of daughter cells. Interval between time
points is 9min, corresponding to every third time point of Supplementary Movie 1. (d) Localization of Mto2-GFP (mildly overexpressed from nmt81
promoter) in nmt81:mto1[NE] cells, together with g-TuSC protein Alp4 (homolog of mammalian GCP2 and budding yeast Spc97p) fused to tandem dimer-
Tomato (Alp4-tdT) in interphase and mitosis. Lower panels show that Alp4-tdTsignal at NE in interphase cells is not a result of ﬂuorescence bleed-through.
(e) Localization of Mto2-GFP (mildly overexpressed from nmt81 promoter) in mto1[bonsai] cells, together with mCherry-tubulin (mCh-Atb2) in interphase
and mitosis. Note presence of Mto2-GFP puncta in interphase and absence of puncta in mitotic cells. All images are Z-projections; individual Z-sections
show NE-associated Mto1/2 complex on the NE and not in nuclear interior. Scale bars, 5 mm.
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cells versus interphase cells was similarly decreased, consistent
with the absence of an intact Mto1/2 complex33.
To conﬁrm that Mto2 hyperphosphorylation and disruption of
the Mto1–Mto2 interaction were not artefacts of an extended
mitotic arrest, we repeated Mto1-SZZ pulldowns in cells under-
going synchronized mitosis after release from a G2/M arrest. In
these experiments, we observed hyperphosphorylation of Mto2 as
cells entered mitosis and hypophosphorylation in early stages of
the subsequent cell cycle (Fig. 2b), and Mto1-SZZ pulldowns
revealed a negative relationship between levels of Mto2
phosphorylation and the strength of the Mto1–Mto2 interaction.
In mitosis, when Mto2 was hyperphosphorylated, the Mto1–
Mto2 interaction was weakest; conversely, at early stages of the
next cell cycle, when Mto2 was hypophosphorylated, the Mto1–
Mto2 interaction was strongest.
Collectively, these experiments establish a strong correlation
between mitotic phosphorylation of Mto2 and disruption of the
Mto1–Mto2 interaction, suggesting that Mto2 phosphorylation
may play an important causal role in the mitotic disassembly of
Mto1/2 puncta observed in vivo. We reasoned that the best test of
this hypothesis would be to mutate phosphorylated amino-acid
residues within Mto2 to non-phosphorylatable residues: if Mto2
phosphorylation were indeed a major driver of mitotic Mto1/2
complex disassembly, then Mto1/2 complex containing non-
phosphorylatable Mto2 might retain interphase-like properties,
such as punctum formation and, possibly, MT nucleation, in
mitotic cells.
Identifying phosphorylation sites within Mto2. To identify
phosphorylation sites within Mto2, we combined sequence ana-
lysis with experimental identiﬁcation by mass spectrometry.
Consistent with the prediction that Mto2 contains several
intrinsically unstructured regions (Supplementary Fig. 1a), the
Mto2 sequence is particularly rich in phosphorylatable residues,
particularly serine (72, 20 and 14 serine, threonine and tyrosine
residues, respectively, within a total of 397 amino-acid residues).
Further analysis revealed at least 45 probable phosphorylation
sites (NetPhos neural network algorithm)42 but relatively few
strong consensus sites for mitotic protein kinases (for example,
three sites for cyclin-dependent kinase Cdc2, three sites for
Aurora kinase Ark1, and four sites for Polo kinase Plo1 (see
Supplementary Table 1). We identiﬁed (uncharacterized) Mto2
homologs in Schizosaccharomyces species as well as in
ﬁlamentous fungi, including several plant, animal and human
pathogens (Supplementary Figs 1,2). However, apart from two
predicted alpha-helical regions, sequence conservation across all
species was very low. We therefore used a tandem 6xHis and
biotinylation tag (‘HTB tag’)43 to partially purify Mto2 from
ﬁssion yeast extracts. By mass spectrometry we identiﬁed
B20 high-conﬁdence phosphorylation sites within Mto2
(Supplementary Fig. 3, Supplementary Table 1, Supplementary
Data 1). We then combined experimental data with sequence
analysis to design Mto2 mutants in which phosphorylatable
residues were replaced by alanine, taking several factors into
account: ﬁrst, some candidate phosphorylation sites might be
refractory to identiﬁcation, especially if present within multi-
phosphorylated peptides, which can be difﬁcult to detect
experimentally44,45. Second, not all experimentally identiﬁed
phosphorylation sites are likely to be involved in cell cycle
regulation of Mto1/2, because Mto2 exists in multiple
phosphoisoforms even in interphase cells (Fig. 2; see also
Fig. 3b, Fig. 4a, Fig. 5b–d), and also because some identiﬁed
sites may be low-stoichiometry sites. Finally, simultaneous
Mto1
Mto2
Gtb1
mto1-SZZ : + + +
mto2 : + + +
nda3 : + + cs cs
I/M: I I I M
+ + +
+ + +
+ + cs cs
I I I M
Cell extracts IgG pulldown
a
0 30 60 90 120 150 180 210
10
30
50
70
90
0.0
0.2
0.4
0.6
0.8
1.0
b
0
0.25
0.50
0.75
1.0
Cy
clin
g 
IgG pulldown
Cell extracts
Cy
clin
g 
0 60
 
90
 
12
0 15
0 
18
0 21
0 
30
 
0 60
 
90
 
12
0 
15
0 
18
0 
21
0 
30
 
Mto1-SZZ
Mto2
Mto1-SZZ
Mto2
m
to
2
+  
(M
)
m
to
2Δ
 
(I)
m
to
2
+  
(I)
0
0.25
0.50
0.75
1.0
200
45
66
200
66
200
66
kDa
kDa
kDa
45
45
10
0 80 88 76 93 10
0
10
39197898691828474 9190
Relative Mto2
Δ Δ
Mto2 in pulldown
(normalized units)
Gtb1 in pulldown
(normalized units)
Minutes after release 
from G2/M block:– –
Minutes after release 
from G2/M block:
Minutes after release from G2/M block
Septation index
(percent cells)
Mto2 in pulldown
(normalized  units)
Expression:
Figure 2 | Mitotic Mto2 hyperphosphorylation coincides with disruption of Mto1–Mto2 interaction. (a) Anti-Mto1, anti-Mto2 and Anti-Gtb1 (S. pombe
g-tubulin) western blots of cell extracts and IgG pulldowns from interphase and metaphase-arrested cells expressing Mto1-SZZ (Protein A tag).
Graphs show quantiﬁcation of Mto2 and Gtb1 copurifying with Mto1-SZZ in the pulldowns above, normalized to the values for mto2þ interphase cells
(central column; see Methods). I, interphase; M, mitosis; cs, cold-sensitive nda3-KM311 b-tubulin allele, used for metaphase arrest. (b) Anti-Mto1 and
anti-Mto2 western blots of cell extracts and corresponding IgG pulldowns from mto1-SZZ cdc25-22 cells undergoing two synchronous mitoses after release
from G2/M arrest. Mto2 expression levels are relative to interphase cycling cells (ﬁrst lane, set to 100; see Methods). Graph shows septation index
(blue line) and quantiﬁcation of Mto2 copurifying with Mto1-SZZ at each time point (red bars), normalized to the 105min time point (see Methods).
Note that second mitosis is not as synchronous as the ﬁrst.
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mutation of a large number of residues could be deleterious to
Mto2 function.
We constructed mto2 mutants in which 6, 13 or 17 serine or
threonine codons were replaced by alanine at the endogenous
mto2 locus; we refer to the mutants as mto2[6A], mto2[13A] and
mto2[17A], respectively (Fig. 3a). Most of the mutations are at
[S/T]-[P] sites (6/6, 9/13 and 13/17 in mto2[6A], mto2[13A] and
mto2[17A], respectively; see Supplementary Table 1), which could
be substrates for cyclin-dependent kinases or mitogen-activated
protein kinases46.
Western blotting of interphase cell extracts from the mto2-
phosphomutant strains revealed migration shifts consistent with
progressively less Mto2 phosphorylation as the number of
phosphosite mutations increased (Fig. 3b). In particular, on
Phos-tag SDS–PAGE, migration of interphase Mto2[17A] was
nearly identical to that of wild-type Mto2 treated with lambda
phosphatase (see Fig. 5d, lanes 4 and 5, 14–17). By contrast, total
levels of phosphomutant Mto2 protein were comparable among
all strains. We conclude that the Mto2-phosphomutant proteins
have signiﬁcantly decreased phosphorylation in vivo.
Interphase microtubule nucleation by phosphomutant Mto2.
We ﬁrst characterized mto2-phosphomutant strains during
interphase, to test for any deleterious effects on Mto2 function.
Surprisingly, we found that mto2-phosphomutant strains were in
fact more competent for MT nucleation than wild-type (mto2þ )
cells. This was conﬁrmed both by quantiﬁcation of interphase MT
bundles and by direct observation of MT nucleation in cells
expressing GFP-tubulin (Fig. 3c,d, Supplementary Movie 2). In
ﬁssion yeast, interphase MTs are organized into bundles
that are typically composed of 2–7 individual MTs not resolvable
by light microscopy47. Compared with wild-type cells, mto2-
phosphomutant strains showed signiﬁcantly higher percentages of
cells with 4–7 bundles, and signiﬁcantly lower percentages of cells
with 0–3 bundles (Fig. 3c). To investigate this further, we
measured MT nucleation frequency by time-lapse ﬂuorescence
videomicroscopy (Fig. 3d, Supplementary Movie 2). Compared
with wild-type cells, median MT nucleation frequency was
increased 2-fold in mto2[6A] cells, 3-fold in mto2[13A] cells
and 4-fold in mto2[17A] cells.
These increases in nucleation frequency were mirrored by
similar increases in the interaction of phosphomutant Mto1/2
complexes with the g-TuC (Fig. 4a). In IgG-bead pulldowns from
mto1-SZZ strains, the amount of g-tubulin copurifying with
Mto1-SZZ was increased B1.5-fold in mto2[6A] cells and
mto2[13A] cells, and nearly 3-fold in mto2[17A] cells, relative
to wild-type cells. By contrast, the amount of Mto2 copurifying
with Mto1-SZZ was similar in all strains (Fig. 4a).
Efﬁcient interaction of Mto1/2 complex with the g-TuC is
thought to require not only a binary interaction between Mto1
and Mto2 but also a multimeric form of Mto1/2 complex32. We
thus hypothesized that the presence of phosphomutant Mto2 in
the Mto1/2 complex may result in increased stability of
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Figure 3 | Phosphomutant Mto2 proteins are potent interphase microtubule nucleators in vivo. (a) Schematic representation showing distribution of
serine and threonine residues in wild-type Mto2 (blue, total 92 residues; 14 tyrosines residues are not shown), together with sites mutated in
phosphomutant Mto2 proteins (red). Mutated sites that were experimentally identiﬁed as phosphorylated are indicated in bold (these are a subset of total
identiﬁed phosphosites; see Supplementary Table 1). Mutated residues are also shown in Supplementary Fig. 2. (b) Anti-Mto2 western blot showing altered
Mto2 mobility on SDS–PAGE in mto2-phosphomutant cells. Mto2 expression levels are relative to interphase mto2þ cells (second lane, set to 100; see
Methods). I, interphase; M, mitosis; cs, cold-sensitive nda3-KM311 b-tubulin allele, used for metaphase arrest. (c) Quantiﬁcation of microtubule bundle
number per cell in the strains indicated, expressing GFP-tubulin. Images and cartoons at left indicate method of quantiﬁcation. 70 cells were scored for each
strain. P-values (Wilcoxon rank-sum test): mto2þ versus mto2-phosphomutant cells, Po1e-3. (d) Quantiﬁcation of microtubule nucleation events per cell
during a 10min interval in the strains indicated, expressing GFP-tubulin. Fifty cells were scored for each strain. Median with interquartile range is shown in
red. **Po1e-3, ***Po1e-4 (Wilcoxon rank-sum test). See also Supplementary Movie 2.
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multimeric Mto1/2, thereby leading to more stable interaction
with the g-TuC. To investigate this, we imaged cells expressing
GFP-tagged phosphomutant Mto2. Like wild-type Mto2-GFP,
phosphomutant Mto2-GFP in interphase cells was present at
SPBs and as puncta on cytoplasmic MTs and the NE (Fig. 4b).
Interestingly, phosphomutant Mto2[13A]-GFP and Mto2[17A]-
GFP puncta showed both higher total ﬂuorescent signals and
higher average pixel intensities than wild-type Mto2-GFP puncta
(Fig. 4c). These results are consistent with phosphomutant Mto2
leading to more stable multimeric Mto1/2 complexes in
interphase cells. We also found that in an mto1D genetic
background, Mto2[17A]-GFP puncta were signiﬁcantly more
prominent than wild-type Mto2-GFP puncta (Fig. 4b; because of
the faintness and diffusion of puncta in mto1D cells, it was not
possible to accurately quantify differences in puncta among these
different strains). Because wild-type Mto2-GFP puncta in mto1D
cells are thought to represent homo-oligomers of Mto2 (ref. 32),
this suggests that the increased stability of phosphomutant Mto1/
2 puncta may be due at least in part to increased interaction of
Mto2 with itself. In summary, increasing the number of non-
phosphorylatable residues within Mto2 leads to more stable and
more active interphase Mto1/2 complexes.
SILAC quantiﬁcation of mitotic Mto2 non-phosphopeptides.
On western blots, all three phosphomutant Mto2 proteins dis-
played slower-migrating isoforms in extracts from mitotically
arrested cells compared with interphase cells (Fig. 3b). In parti-
cular, the majority of Mto2[17A] showed a discrete migration
shift that was found to be due to mitosis-speciﬁc phosphorylation
(see Fig. 5d, lanes 4–5, 14–17). This suggested that in spite of the
effects of phosphomutant Mto2 on interphase MT nucleation,
additional mitosis-speciﬁc phosphorylation may be important in
regulating the Mto1/2 complex. We therefore sought to identify
the relevant mitosis-speciﬁc phosphorylation sites still present in
phosphomutant Mto2[17A].
We used SILAC (stable isotope labelling by amino acids in
culture) mass spectrometry37,38 to compare Mto2[17A]-GFP
immunopuriﬁed from interphase cells and from mitotically
arrested cells (Supplementary Fig. 4). We identiﬁed B17
different phosphorylation sites within Mto2[17A]-GFP, and for
several of these we were able to quantify relative abundance in
interphase versus mitosis (Supplementary Fig. 4b, Supplementary
Table 1, Supplementary Data 2). However, as a screening
tool to identify candidate residues involved in mitosis-speciﬁc
phosphoregulation, we focused our analysis instead on
quantiﬁcation of non-phosphopeptides39,40. The motivations for
this are described in detail in the Supplementary Methods; here
we will mention only that for a protein such as Mto2[17A], in
which a signiﬁcant mole fraction undergoes a mitosis-speciﬁc
migration shift (Figs 3b and 5d), and most tryptic peptides
contain multiple phosphorylatable residues, this approach is
likely to produce the fewest ‘false-negative’ results.
We obtained quantitative data for non-phosphopeptides
comprising 91% of the Mto2[17A] amino-acid sequence (361/
397 residues; Supplementary Data 3). This revealed ﬁve regions of
Mto2[17A] for which non-phosphopeptide abundance was
signiﬁcantly greater in interphase versus mitotic cells (Fig. 5a),
suggesting that these regions—termed NT1, NT2, FCC, CT1 and
CT2—may be subject to high-stoichiometry modiﬁcation in
mitosis (see Supplementary Methods). In these regions several
serine and threonine residues were identiﬁed as being phos-
phorylated (Supplementary Fig. 4b, Supplementary Table 1,
Supplementary Data 2).
Taking these ﬁve regions as candidate-regions for mitosis-
speciﬁc phosphorylation, we constructed a second-generation
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series of mutants, derived from mto2[17A], in which all serines
and threonines within a given region (and, in one case, one
tyrosine) were mutated to alanine, in addition to the mutations
already present in mto2[17A] (Supplementary Table 1,
Supplementary Fig. 5a). Notably, the second-generation mutant
protein containing phosphosite mutations in the NT2
region, which we named Mto2[24A], displayed signiﬁcantly
decreased mitotic phosphorylation compared to Mto2[17A]
(Fig. 5b,d). By contrast, other second-generation mutant proteins
(which are named according to the region mutated) were
indistinguishable from Mto2[17A] in both interphase and
mitosis (Fig. 5b). We therefore investigated the mto2[24A]
mutant in more detail.
Mto2[24A] retains interphase-like properties in mitosis. Dur-
ing interphase, the properties of mto2[24A] mutants were nearly
identical to those of mto2[17A] mutants, in relation to MT bundle
number and nucleation frequency, physical interaction of Mto1/2
with the g-TuC, and appearance of Mto2 puncta upon GFP-
tagging (Fig. 5c, Supplementary Fig. 5b–d). This indicates that
Mto2[24A] is fully functional for interphase MT nucleation
in vivo and indeed, like Mto2[17A], is a signiﬁcantly ‘better’
nucleator than wild-type Mto2, most likely as a consequence of
increased stability of the Mto1/2 complex.
To study the properties of phosphomutant Mto2 during
mitosis, we ﬁrst investigated the interaction of phosphomutant
Mto2[6A], Mto2[13A], Mto2[17A] and Mto2[24A] with SZZ-
tagged Mto1 and the g-TuC in interphase versus mitotically
arrested cells (Fig. 5c). Interestingly, unlike wild-type cells, in all
mto2-phosphomutant cells the amount of Mto2 copurifying with
Mto1-SZZ was approximately as high during mitosis as it was
during interphase. The amount of g-tubulin copurifying with
Mto1-SZZ during mitosis also remained high in mto2[13A],
mto2[17A] and mto2[24A] cells, again in contrast to wild-type
cells. In mto2[6A] cells, which contain fewer phosphosite
mutations, the amount of g-tubulin copurifying with Mto1-SZZ
during mitosis was decreased relative to interphase, but not as
dramatically as in wild-type cells.
Based on these results, we examined the localization of
GFP-tagged Mto2-phosphomutant proteins during mitosis
(Figs 6 and 7a, Supplementary Fig. 6). Consistent with previous
work, in mitotic cells wild-type Mto2-GFP was observed only at
SPBs, and no other puncta were observed29–31; Mto2[6A]-GFP
showed a similar localization. In mitotic cells Mto2[13A]-GFP
and Mto2[17A]-GFP were observed not only at SPBs but also
occasionally as faint puncta on the NE, and Mto2[24A]-GFP was
observed both at SPBs and as much more prominent puncta on
the NE (Fig. 6a, Supplementary Fig. 6a; see Discussion for why
these appear speciﬁcally on the NE). Quantiﬁcation revealed that
the non-SPB ﬂuorescent signal of mitotic NE-associated
Mto2[24A]-GFP puncta was signiﬁcantly greater than that of
Mto2[17A]-GFP and the four other second-generation
phosphomutant Mto2-GFPs (Fig. 6b).
In these experiments we noticed that the mitotic SPB
ﬂuorescent signal of phosphomutant Mto2-GFP was also greater
than that of wild-type Mto2-GFP (see, for example, Fig. 6a); this
raised the possibility that mitotic NE-associated puncta of
phosphomutant Mto2-GFP might be derived from fragments or
remnants of SPBs. We therefore imaged Mto2[24A]-GFP and
Mto2[17A]-GFP in mto1[NE] cells, in which the Mto1/2 complex
is unable to localize to SPBs32. In mitotic mto1[NE] cells,
phosphomutant Mto2-GFPs were still observed in NE-associated
puncta (Fig. 6c, Supplementary Fig. 6b), demonstrating that these
puncta are generated independently of any localization to SPBs.
Given these observations, we next investigated whether
mto2-phosphomutant cells are competent for Mto1/2-dependent
cytoplasmic MT nucleation during mitosis. We imaged and
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quantiﬁed cytoplasmic MTs (mCherry-tubulin) in mitotic mto2-
GFP, mto2[17A]-GFP and mto2[24A]-GFP cells (Fig. 7a,b,
Supplementary Movie 3). In cells with very short spindles
(Fig. 7b blue zone, roughly corresponding to prometaphase), a
signiﬁcant proportion of cells of all genotypes contained one or
more cytoplasmic MTs, indicating that at this stage of mitosis,
disassembly of interphase cytoplasmic MTs is not yet complete.
In cells with short spindles (Fig. 7b green zone, roughly
corresponding to metaphase), 11% of mto2[24A]-GFP cells and
5% of mto2[17A]-GFP cells contained cytoplasmic MTs, while
such MTs were never observed in wild-type mto2-GFP cells.
Moreover, in cells with medium-to-long spindles (Fig. 7b orange
zone, roughly corresponding to early-to-mid-anaphase), 46% of
mto2[24A]-GFP cells and 35% of mto2[17A]-GFP cells contained
cytoplasmic MTs, while, again, such MTs were never observed in
wild-type mto2-GFP cells.
To conﬁrm that the presence of cytoplasmic MTs in mitotic
mto2[24A]-GFP cells and mto2[17A]-GFP cells was not depen-
dent on GFP-tagging, we analysed untagged wild-type (mto2þ ),
mto2[17A] and mto2[24A] cells expressing GFP-tagged g-TuSC
protein Alp4 and mCherry-tubulin (Fig. 7c-e). In contrast to the
wild-type cells, nearly all mitotic mto2[24A] cells displayed NE-
associated Alp4-GFP puncta independent of SPBs, and these were
signiﬁcantly brighter than the occasional equivalent puncta
observed in mto2[17A] cells. This suggests that Mto1/2 complex
containing Mto2[24A] has a stronger association with the g-TuC
during mitosis in vivo than does Mto1/2 complex containing
Mto2[17A]. Accordingly, in mto2[24A] cells with short spindles,
we observed one or more cytoplasmic MTs in 16% of mitotic
cells, and these were associated with NE-associated Alp4-GFP
puncta. Such MTs were present in only 5% of mto2[17A] cells,
and never in wild-type (mto2þ ) cells.
The number of cytoplasmic MT bundles per cell observed in
mitotic mto2[24A] cells and, to a lesser extent, mto2[17A] cells is
striking compared with mitotic wild-type (mto2þ ) cells (Fig. 7b)
but nevertheless not as high as in interphase cells (see, for
example, Supplementary Fig. 5a). One likely reason for this may
be that during mitosis, multiple additional mechanisms operate in
parallel with Mto2 phosphorylation to favour intranuclear mitotic
spindle assembly versus cytoplasmic MT nucleation48–53. To
investigate this, we quantiﬁed cytoplasmic MTs during mitosis in
wild-type, mto2[17A] and mto2[24A] cells in a temperature-
sensitive pim1-F201S genetic background. Pim1 is the ﬁssion
yeast ortholog of human RCC1, the guanine nucleotide exchange
factor for Ran GTPase, required for proper nucleocytoplasmic
transport54–56. At non-permissive temperature (37C), pim1-
F201S mutants exhibit a partial loss-of-function and have a range
of defects in mitotic spindle assembly, due to decreased intra-
nuclear localization of several proteins, including the TACC
protein Alp7 and the ch-TOG protein Alp14 (refs 51,56). For
these experiments we used increased localization of GFP-tagged
Polo kinase Plo1 to the SPB as an indicator of mitotic onset, as
this increase occurs independently of assembly of mitotic spindle
MTs57,58. Interestingly, we found that in the pim1-F201S
background at non-permissive temperature, 43% of all mitotic
mto2[24A] cells and 41% of all mitotic mto2[17A] cells contained
cytoplasmic MTs, compared with 13% of all wild-type (mto2þ )
cells (Supplementary Fig. 7). Further examination revealed that
this was largely although not exclusively because of the fact that a
signiﬁcant proportion of mitotic mto2[24A] and mto2[17A] cells
contained unseparated SPBs, compared with wild-type cells
(27, 25 and 9%, respectively; Supplementary Fig. 7). Overall,
these results suggest that mitotic cytoplasmic MT nucleation in
mto2-phosphomutant cells is limited at least in part by additional
mechanisms that normally promote spindle assembly; when these
mechanisms are compromised, cytoplasmic MT nucleation by
phosphomutant Mto2 can exacerbate spindle assembly defects,
particularly during the earliest stages of spindle assembly.
Collectively, our results indicate that mto2-phosphomutant
cells, in particular mto2[24A], retain interphase-like properties in
mitotic cells. This strongly supports the hypothesis that Mto2
phosphorylation during mitosis negatively regulates the Mto1/2
complex. However, it remained formally possible, albeit unlikely,
that the phenotypes of mto2-phosphomutant cells are due not to
decreased phosphorylation but rather to nonspeciﬁc effects
resulting from simultaneous mutation of multiple amino-acid
residues. We therefore constructed mto2[24D] and mto2[24E]
phosphomimetic mutants, in which all residues mutated to
alanine in mto2[24A] were instead mutated to aspartate and
glutamate, respectively. According to our hypothesis, phospho-
mimetic Mto2 would be predicted to show ‘mitotic-like’
behaviour during interphase—that is, impaired function relative
to wild-type interphase Mto2 and phosphomutant Mto2.
Consistent with this, we found that unlike wild-type Mto2 and
other phosphomutant Mto2 proteins, only negligible amounts of
interphase Mto2[24D] and Mto2[24E] copuriﬁed with Mto1-SZZ,
and in these cells the g-TuC also failed to copurify with Mto1-
SZZ (Supplementary Fig. 8a). In addition, GFP-tagged
Mto2[24D] and Mto2[24E] formed far fewer cytoplasmic puncta
compared with Mto2-GFP during interphase, and quantiﬁcation
of MT bundle number revealed that mto2[24D]-GFP and
mto2[24E]-GFP mutants contained signiﬁcantly fewer interphase
MT bundles than wild-type (mto2-GFP) cells and indeed more
closely resembled mto2D cells (Supplementary Fig. 8b,c). Thus
Figure 7 | Mto2[24A] promotes interphase-like microtubule nucleation in mitosis. (a) Time-lapse images (1.6 s interval) of wild-type and
phosphomutant Mto2-GFP in mitosis, co-imaged with mCherry-tubulin (mCh-Atb2). Magenta arrow indicates cytoplasmic microtubule (MT) nucleation
event; green arrow indicates Mto2[24A]-GFP localized to MT. See Supplementary Movie 3 for corresponding movie. (b) Quantiﬁcation of cytoplasmic MTs
(mCherry-tubulin) in mitotic wild-type mto2-GFP (WT) and phosphomutant mto2[17A]-GFP and mto2[24A]-GFP cells (n¼ 240, 244 and 228 cells,
respectively). Data set was divided into three bins based on mitotic spindle length, roughly corresponding to prometaphase, metaphase and early-to-mid
anaphase (blue, green and orange shading, respectively). Coloured tables in each bin show percent of mitotic cells within that bin containing one or more
cytoplasmic MTs, for each genotype. Table in black shows this for all three bins combined. Statistical signiﬁcance analyses were performed separately for
each bin and are presented in corresponding colours. **Po0.05, ***Po0.01, ****Po1e-7 (Wilcoxon rank-sum test, one tailed). (c) Mitotic localization of g-
TuSC protein Alp4 fused to GFP (Alp4-GFP), together with mCherry-tubulin (mCh-Atb2), in wild-type and mto2-phosphomutant cells, as indicated. Note
localization of Alp4-GFP to the nuclear envelope (NE) in mto2[24A] cells, and weaker localization to NE in mto2[17A] cells. Magenta arrows indicate
cytoplasmic MTs; green arrow indicates Alp4-GFP localized to cytoplasmic MT. (d) Quantiﬁcation of total ﬂuorescence signal of Alp4-GFP at the NE in
mitotic wild-type and mto2-phosphomutant cells, as indicated (n¼ 36, 58 and 43 cells, respectively). Fluorescence signal at SPBs was excluded from
analysis (see Methods). Median with interquartile range is shown in red. **Po1e-3, ***Po1e-9 (Wilcoxon rank-sum test, two-tailed). (e) Quantiﬁcation of
cytoplasmic MTs in mitosis in wild-type and mto2-phosphomutant cells expressing Alp4-GFP and mCherry-tubulin. Percent of cells containing one or more
cytoplasmic MTs is shown, for cells with spindle lengths between 1 and 4mm (n¼ 126, 138 and 118 cells, respectively). ***Po0.01 (Fisher’s exact test, two-
tailed). All images are Z-projections; individual Z-sections show NE-associated Mto1/2 complex on the NE and not in nuclear interior. Scale bars, 5 mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8929 ARTICLE
NATURE COMMUNICATIONS | 6:7929 | DOI: 10.1038/ncomms8929 | www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
the phenotypes of mto2-phosphomimetic mutants support our
interpretation of mto2-phosphomutant phenotypes.
Discussion
In spite of recent advances in understanding of mechanisms of
MT nucleation in vivo, much remains to be learned about
their regulation during the cell cycle, as well as during cell
differentiation1,5,6. In particular, little is known about how certain
modes of nucleation are ‘switched off’ at the same time as
other modes of nucleation are ‘switched on’. Our results here
suggest a model for cell cycle regulation of cytoplasmic MT
nucleation in ﬁssion yeast, in which multisite phosphorylation
of Mto2 modulates the assembly and/or stability of the
multimeric Mto1/2 complex (Fig. 8). During mitosis, when
the intranuclear mitotic spindle is assembled, Mto2 becomes
hyperphosphorylated, coincident with disassembly of the
Mto1/2 complex, as demonstrated both by the disappearance of
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Mto2-GFP puncta in vivo and by the loss of physical interaction
between Mto1 and Mto2, which in turn leads to loss of
interaction with the g-TuC. By mutating multiple
experimentally identiﬁed and candidate phosphorylation sites
within Mto2, we generated a series of phosphomutant versions of
Mto2, including Mto2[24A], which has only a very low level of
phosphorylation in both interphase and mitosis. During
interphase, all mto2-phosphomutant cells nucleate more MTs
than wild-type cells, and nucleation frequency increases with the
number of mutations, in a graded manner. Notably, during
mitosis, when Mto1/2 complexes in wild-type cells disassemble,
Mto1/2 complexes in mto2[24A] mutant cells (and, to a lesser
extent, mto2[17A] cells) retain interphase-like behaviour,
remaining intact and capable of nucleating cytoplasmic MTs.
Conversely, phosphomimetic mto2[24D] and mto2[24E] mutants
show strongly impaired, ‘mitotic-like’ behaviour in interphase. It
is important to note that mto2[24D] and mto2[24E] phenotypes
could in principle be due to nonspeciﬁc effects rather than
mimicking mitotic hyperphosphorylation per se, particularly
because it is not clear whether all 24 sites would be
simultaneously phosphorylated on a single wild-type Mto2
molecule in vivo. However, because both Mto2[24D] and
(especially) Mto2[24E] are expressed at levels similar to wild-
type Mto2, and both proteins show some limited localization
in vivo, both are likely properly folded to some extent.
Furthermore, even if some mto2-phosphomimetic phenotypes
were due in part to nonspeciﬁc effects, the fact that these
phenotypes are completely different from mto2-phosphomutant
phenotypes strongly argues against the possibility that the mto2-
phosphomutant phenotypes themselves are due to nonspeciﬁc
effects.
The mto2[24A] phosphomutant was generated as a result of
quantifying Mto2[17A] non-phosphopeptides in interphase
versus mitosis; this identiﬁed candidate-regions in which to
mutate serine and threonine residues to alanine. Among the ﬁve
regions mutated, the NT2 region, which is mutated in mto2[24A],
was the only one in which we did not directly identify
phosphopeptides from Mto2[17A] by mass spectrometry
(Supplementary Table 1, Supplementary Data 2). This illustrates
the potential power of our approach, especially when direct mass
spectrometric evidence for phosphorylation may not be forth-
coming (see Supplementary Methods for further discussion). We
would argue that such an approach can be valid provided it is
accompanied by additional analysis (for example, western blots of
Phos-tag gels). It remains formally possible that mutation within
the NT2 region leads to a loss of phosphorylation elsewhere in the
protein. However, given our additional ﬁnding that mutation of
phosphorylatable residues in all other regions tested (NT1, FCC,
CT1 and CT2) did not alter migration relative to Mto2[17A]
(Fig. 5b), this could be considered unlikely.
Although both mto2[17A] and mto2[24A] mutants show
strongly enhanced interphase MT nucleation, and both
Mto2[24A] and Mto2[17A] proteins can physically interact with
Mto1 and the g-TuC during mitosis, mto2[24A] mutants display
signiﬁcantly stronger interphase-like behaviour during mitosis.
The simplest interpretation of these results is that distributed,
multisite phosphorylation of Mto2 (a protein with several
predicted disordered regions) alters multiple aspects of Mto2
function in the context of the Mto1/2 protein complex (Fig. 8b),
and that the cumulative effects of this are most strongly abrogated
in Mto2[24A]. In vivo, actively nucleating Mto1/2 complex is
present as higher-order multimers that interact with multiple
g-TuSCs, with an estimatedB13 copies of Mto1 and of Mto2 in
each nucleating complex32. Moreover, in addition to interacting
with Mto1, Mto2 also interacts with itself32, and also possibly
very weakly with the g-TuC, independent of interaction with
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Figure 8 | Model for regulation of Mto1/2 complex assembly and activity by phosphorylation. (a) Schematic diagram showing how the activity of
wild-type and phosphomutant Mto1/2 complex is regulated by phosphorylation. Diagram depicts negative relationship between Mto2 phosphorylation
(red) and Mto1/2-dependent microtubule (MT) nucleation (blue), aligned with range of Mto2 phosphorylation states in interphase (I) and mitosis (M) in
wild-type Mto2 and Mto2 phosphomutants (grey bars). In wild-type cells, interphase levels of Mto2 phosphorylation allow efﬁcient interaction with Mto1
and g-TuC binding, leading to Mto1/2 complex puncta formation and microtubule (MT) nucleation; mitotic hyperphosphorylation of Mto2 abolishes
these interactions, leading to suppression of microtubule nucleation. In mto2-phosphomutant cells, increasing the number of mutated phosphosites leads to
a graded decrease in Mto2 phosphorylation and a corresponding graded increase in Mto1/2 activity in interphase and mitosis. (b) Role of Mto2
phosphorylation in context of model for Mto1/2 complex assembly proposed by Lynch et al.32. Several different aspects of Mto1/2 assembly and activity
may be regulated by Mto2 phosphorylation in both interphase and mitosis, with higher levels of phosphorylation in mitosis. Interaction between the Mto1/2
multimer and g-TuSCs might be regulated either directly, by altering afﬁnity between Mto2 and g-TuSCs, or indirectly, by altering the multimeric state of the
Mto1/2 complex, thereby affecting cooperative binding to g-TuSCs. MT, microtubule.
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Mto1 (ref. 33). Although the detailed architecture of the Mto1/2
complex remains unknown, we would speculate that within this
context, a gradation of levels of Mto2 phosphorylation would lead
to a gradation of phenotypes, because of the quantitative effects
on protein–protein interactions as well on protein conformation.
In the future, this would best be investigated with puriﬁed wild-
type and mutant proteins.
The cytoplasmic MT nucleation seen in mitotic mto2[24A] cells
is not as robust as in interphase cells, and our observations in
pim1-F201S cells suggest that this is due at least in part to
additional mechanisms that normally promote intranuclear
mitotic spindle assembly at the expense of cytoplasmic MT
assembly. Many of the proteins that stabilize interphase
cytoplasmic MTs in ﬁssion yeast also stabilize mitotic spindle
MTs and thus are imported into the nucleus during mitosis; these
include the TACC protein Alp7 and the ch-TOG protein Alp14
(refs 51–53), as well as the MT-bundling protein (PRC1 homolog)
Ase1 (refs 49,50). In addition, in the related ﬁlamentous fungus
Aspergillus nidulans, there is evidence for net import of ab-tubulin
dimer into the nucleus speciﬁcally during mitosis48; a similar
mechanism may also operate in ﬁssion yeast. Thus, even if Mto1/2
complexes containing Mto2[24A] can bind to and recruit g-TuSCs
(for example, Alp4-GFP) during mitosis, a scarcity of other factors
may preclude an extensive cytoplasmic MT polymerization. This
underscores the notion that disassembly of the Mto1/2 complex by
Mto2 phosphorylation is likely to be one of several redundant
mechanisms working in concert to switch off cytoplasmic
MT polymerization during mitosis, simultaneously favouring
intranuclear spindle MT polymerization.
The level of mitotic cytoplasmic MT nucleation in mto2[24A]
mutants also provides an explanation for why mitotic puncta of
Mto2[24A]-GFP (and Mto2[17A]-GFP) appear primarily on the
NE, as do Alp4-GFP mitotic puncta in mto2[24A] cells. In wild-
type interphase cells, Mto1/2 complex localizes to the NE if MTs
are depolymerized by drug- or cold-treatment28,29, and in
mto1[NE] cells, in which the MT-binding region of Mto1 is
deleted, a similar localization to the NE occurs even without such
treatment32 (Fig. 1b–d)—in other words, in the absence of MT
binding, interphase Mto1/2 binds by default to the NE32. We
propose that this also occurs for mitotic Mto1/2 containing
Mto2[24A]. Although the molecular basis of Mto1/2 binding to
the NE remains unknown, we consider it unlikely that mitotic
Mto2[24A]-GFP puncta bind preferentially to the NE relative to
MTs, because mitotic Mto2[24A]-GFP puncta were present not
only on the NE but also on the few cytoplasmic MTs present
in mitotic mto2[24A]-GFP cells, and similar results were
obtained for Alp4-GFP puncta in mto2[24A] cells. (Fig. 7a,c,
Supplementary Movie 3).
It might at ﬁrst seem puzzling that mto2[24A] mutants do not
show increased astral MT nucleation (that is, cytoplasmic MT
nucleation from the SPBs) during mitosis; however, this is
actually what one would predict. Although astral MT nucleation
requires Mto1, it does not require Mto2 (refs 29–31), and thus
astral nucleation would not be expected to be regulated by Mto2
phosphorylation.
Currently we do not know the identity of the protein kinase, or
kinases, phosphorylating Mto2. Given the number and diversity
of phosphosites, and the fact that Mto2 exists as multiple
phosphorylated isoforms in interphase as well as mitosis, it is
likely that multiple kinases are involved. It is not yet clear whether
Mto2 interphase phosphorylation plays a speciﬁc modulatory role
in MT nucleation, for example, at different stages of interphase,
or at different subcellular sites. Preliminary observations suggest
that Mto2-GFP puncta are more prominent in early stages of the
cell cycle (that is, when Mto2 is hypophosphorylated), but the
functional signiﬁcance of this is unknown. One potential reason
for multiple interphase Mto2 isoforms might be that Mto2 is
differentially phosphorylated at different subcellular sites. How-
ever, we consider this unlikely, because Mto2 isoforms appear
identical in wild-type, mto1D and mto1[NE] cells, even though
Mto2 localization differs dramatically among these strains.
The presence of Mto2 homologs in ﬁlamentous fungi,
including Aspergillus, Neurospora and several pathogens, suggests
that disruption of interphase MT nucleation complexes by mitotic
phosphorylation may be a general mechanism contributing to cell
cycle-dependent regulation of MT nucleation. To date, none of
these homologs has been functionally characterized. Most Mto2
phosphorylation sites lie outside highly conserved (and struc-
tured) regions, but analogous potential phosphorylation sites are
easily identiﬁed in homologs (Supplementary Fig. 2). This is
consistent with the notion that multisite phosphorylation of the
type proposed here may result in broad region-speciﬁc effects on
protein–protein interactions, rather than precise residue-speciﬁc
conformational changes59,60. Given the sequence divergence
among fungal Mto2 homologs, it is perhaps not surprising that
Mto2 homologs have not yet been identiﬁed in higher eukaryotes.
However, Mto1 homologs are present from yeast to human6,9,28.
Thus in higher eukaryotes there may be proteins functionally
equivalent to Mto2, and these could also be similarly regulated,
and of potential importance particularly in relation to non-
centrosomal MT nucleation.
Methods
Yeast strain construction and growth. Standard ﬁssion yeast methods and
genetic techniques were used throughout61. Tagging and deletions of genes were
performed using PCR-based methods43,62,63. Strains used in this study are listed In
Supplementary Table 2.
To generate Mto2 phosphomutants expressed from the endogenous mto2
promoter, a two-step gene replacement technique was used. For ﬁrst-generation
phosphomutants mto2[6A], mto2[13A] and mto2[17A], nucleotides 77–300 of the
mto2þ coding sequence were ﬁrst replaced by the ura4þ gene, using PCR-based
methods, and the ura4þ gene was then replaced by synthetic DNA fragments
(GeneArt) encoding phosphomutant mto2 alleles. Mutations were conﬁrmed by
DNA sequencing. For second-generation mto2 phosphomutants mto2[NT1],
mto2[24A], mto2[FCC], mto2[CT1], mto2[CT2], mto2[24D] and mto2[24E], the
entire mto2þ ORF was ﬁrst replaced by ura4þ .
For immunoprecipitation and pulldown experiments, cells were grown in YE5S
rich medium. For imaging, cells were grown in EMM2 minimal medium using
5 g l 1 sodium glutamate instead of ammonium chloride as nitrogen source, and
nutritional supplements at 175mg l 1; we will refer to this as ‘minimal medium’61.
All imaging experiments used minimal medium in which nutritional supplements,
sodium glutamate and glucose were added after autoclaving.
For SILAC experiments, cells were grown in SILAC medium (EMM2 with
6mM NH4Cl as nitrogen source, plus 60mg l 1 L-arginine and 80mg l 1
L-lysine38. Arginine and lysine were either unlabelled (‘light’) or heavy-isotope
labelled (‘heavy’). ‘Heavy’ isotope-labelled amino acids were L-13C615N2-lysine
and L-13C6-arginine (Sigma Isotec). To ensure complete labelling with ‘heavy’
amino acids, cells were grown in SILAC media for at least seven generations,
and typically 10 generations. Cells in SILAC experiments were harvested in late
log phase (OD595 2.0).
For mitotic arrest, strains containing the cold-sensitive b-tubulin mutation
nda3-KM311 were grown in YE5S or SILAC medium to OD595 1.0 at 30 C, chilled
in ice-water to 18 C, and then grown at 18 C for 6 h (YE5S) or 8 h (SILAC).
OD595 at harvest wasB1.8. In these experiments, asynchronous cultures grown in
parallel were used as ‘interphase’ cells. The small proportion of mitotic cells present
in asynchronous cultures could essentially be ignored—as seen, for example, by
comparing the migration of Mto2 isoforms on SDS–PAGE in interphase versus
mitosis (Figs 2, 3 and 5).
For G2/M arrest-and-release, strains containing the heat-sensitive cell cycle
phosphatase mutation cdc25-22 were grown in YE5S medium in a water bath to
OD595 0.2 at 25 C and then moved to the restrictive temperature (36 C water
bath). Cells were grown in 36 C for 3 h 30min and then released into permissive
temperature (25 C water bath). Further details are given under Biochemical
Methods.
Microscopy and image analysis. Spinning-disk confocal microscopy was per-
formed using a Nikon TE2000 inverted microscope with a Nikon  100/1.45 NA
PlanApo objective, attached to a modiﬁed Yokogawa CSU-10 unit (Visitech)
and an iXonþ Du888 EMCCD camera (Andor), controlled by Metamorph
software (Molecular Devices)64,65. For simultaneous imaging of Mto2-GFP with
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mCherry-Atb2, and also for co-localization imaging of Mto2-GFP and Alp4-
tdTomato, an Optosplit III image splitter (Cairn Research Ltd) with a T560LPXR
dichroic ﬁlter (Chroma Technology) was used.
Before live-cell microscopy, cells were grown in minimal medium at 25 C for
two days, with appropriate dilution to maintain exponential growth. Imaging was
performed at 25 C in a temperature-regulated chamber built around the
microscope. The only exception to this involved experiments with pim1-F201S
temperature-sensitive mutants, in which cells were grown in YE5S medium for 2
days at 25 C and then shifted for 3 h to 37 C, and imaged with the temperature-
regulated chamber set to 37 C.
Cells were mounted on thin (50 mm) agarose pads containing minimal medium
and 2% agarose, between a coverslip and the microscope slide and sealed with
VALAP66. For long movies (Fig. 1c, Supplementary Movie 1) cells were mounted
on a thick (B1mm) agarose pad, covered with a coverslip and sealed with VALAP
such that a 150ml droplet of minimal medium surrounded the pad to prevent
overdrying.
Image processing was performed using Metamorph (Molecular Devices),
ImageJ, Image Pro, Image-Pro Premier 3D and Photoshop (Adobe). Images were
adjusted using strictly linear contrast enhancement and are presented as maximum
projections of eight Z-sections spaced by 0.6 mm, containing the entire cell volume.
Movies were generated using Quicktime Pro 7 software and Fireworks (Adobe).
Within the same ﬁgure panel or movie, still and time-lapse images for each channel
were acquired and processed identically and thus can be compared directly, except
for Fig. 7a and Supplementary Movie 3, in which contrast for individual cells was
adjusted identically for individual channels, but differently for each merged image,
to highlight the relevant MT nucleation events.
For quantiﬁcation of interphase MT bundles and MT nucleation frequency in
wild-type and mto2-phosphomutant strains, live-cell movies of GFP-tubulin
(nmt81:GFP-Atb2) were used. A nucleation event was deﬁned as the appearance of
a new MT that did not originate from a MT breakage event or from an existing MT
bundle. Nucleation occurring on pre-existing MT bundles was excluded from the
analysis because, as a result of rapid MT bundling and sliding, it cannot be
quantiﬁed with complete conﬁdence32.
For quantiﬁcation of interphase MT bundles in cells expressing GFP-tagged
wild-type, mto2D and mto2-phosphomimetic alleles, still images of mCherry-
tubulin (mCh-Atb2) were used.
For quantiﬁcation of cytoplasmic MTs in mitotic wild-type and mto2-
phosphomutant cells, still images of mCherry-tubulin (mCh-Atb2) were used. In
addition to the number of cytoplasmic MT bundles per cell, mitotic spindle length
was measured, that is, the distance between duplicated SPBs. Cells in which
eMTOC formation was observed or astral-like MTs were observed emanating from
both SPBs were excluded from quantiﬁcation. For analysis presented in Fig. 7b, the
data set was divided into three bins based on spindle length, roughly corresponding
to prometaphase (0–1.4 mm), metaphase (1.4–3.4 mm) and early-to-mid anaphase
(3.4–8.2 mm). For analysis presented in Fig. 7e, only cells with spindle length
between 1 and 4 mm were analysed.
For quantiﬁcation of cytoplasmic MTs in mitotic wild-type and
mto2-phosphomutant cells expressing Plo1-mEGFP in the pim1-F201S background,
still images of mCherry-tubulin (mCh-Atb2) were used. Cells were grown for two
days at 25 C, then for 3 h at 37 C. After this, cells were imaged at 37 C during a
1 h period (that is, the total time at 37 C did not exceed 4 h). Mitotic cells were
identiﬁed by increased Plo1-mEGFP signal at the SPB, which allowed for
quantiﬁcation of cytoplasmic MTs in mitotic cells with ‘zero-length’ spindles (that
is, SPBs not yet separated). In Supplementary Fig. 7, to avoid overcrowding of data
points for ‘zero-length’ spindles, some data points are displayed slightly above or
below the ‘zero’ position on the vertical axis (not more than 0.2 mm greater or
lesser). It should be noted that because of pim1-F201S phenotypes and differences
in experimental conditions (for example, growth medium, temperature and genetic
background), results from experiments with mto2 mutants in pim1-F201S cells are
not directly comparable with results from experiments with mto2 mutants in
pim1þ cells.
For quantiﬁcation of the total signal and pixel area of Mto2-GFP (or
phosphomutant Mto2-GFP) puncta in interphase cells, maximum projections of
entire imaging ﬁelds were generated. Integrated Morphometry Analysis
(Metamorph) was used to measure the total signal and the pixel area of all puncta
in the imaging ﬁeld. Background signal for each imaging ﬁeld (deﬁned as average
pixel intensity of three puncta-free sub-regions) was then subtracted to produce a
ﬁnal corrected value for the puncta signal. For each strain, three imaging ﬁelds were
analysed, and the results were combined to generate plots presented in Fig. 4c.
For quantiﬁcation of the total non-SPB ﬂuorescent signal of mitotic puncta of
Mto2-GFP (or phosphomutant Mto2-GFP) and Alp4-GFP at the NE (Figs 6b and
7d, respectively), maximum projections of images of mitotic cells were generated,
and the NE region was selected manually and copied to a new image ﬁle. After
removing the two brightest Mto2-GFP or Alp4-GFP spots (which correspond to
SPBs), the integrated intensity (that is, total signal) of the NE region was measured.
Background signal for the region (deﬁned as average intensity of a puncta-free
subregion, multiplied by the total number of pixels in the entire region) was then
subtracted to produce a ﬁnal corrected value for the total mitotic puncta signal.
Statistical analysis was performed using R (http://www.r-project.org/). Non-
parametric data were analysed using Wilcoxon rank-sum test (also known as
Mann–Whitney), and categorical data were analysed using Fisher’s exact test.
Biochemical methods. In all experiments except for the pulldown shown in
Fig. 2b, ﬁssion yeast protein extracts were made from yeast cell powder. Cell
powder was made by freezing cell pellets dropwise in liquid nitrogen, followed by
cryogrinding in a Retsch RM100 mortar grinder.
Puriﬁcation of Mto2-HTB before MS analysis was performed using B35 g of
yeast cell powder. Puriﬁcation was in two steps, with the ﬁrst step under denaturing
conditions. In the ﬁrst step, powder was resuspended in denaturation buffer (6M
GuHCl, 25mM Tris-HCl pH 7.5, 300mM NaCl and 20mM imidazole). Lysate was
clariﬁed by two rounds of centrifugation at 7,800g for 20min at 4 C in a Beckman
Avanti J-25 centrifuge using a JA25.50 rotor. 1ml settled bead volume of HisBind
Fractogel (Novagen), previously washed with water and activated with 1ml of 0.5M
NiSO4, was incubated with the clariﬁed lysate for 3 h at 4 C. Resin was batch-washed
six times with 10ml with wash buffer (WB; 25mM Tris-HCl pH 7.5, 300mM NaCl,
20mM imidazole) containing successively lower concentrations of guanidine
hydrochloride (GuHCl, two washes each with 6, 3, 1M GuHCl), and then three
times with 10ml of WB. Protein was eluted from HisBind Fractogel in 5ml of elution
buffer (25mM Tris-HCl pH 7.5, 300mM NaCl, 300mM imidazole, 1mM DTT,
1mM PMSF, 1mM benzamidine, 10mgml 1 each of ‘CLAAPE’ protease inhibitors
(chymostatin, leupeptin, antipain, pepstatin, E64), 60mM b-glycerophosphate,
15mM para-nitrophenyl phosphate, 10mM sodium orthovanadate). In the second
step, B4.5 108 beads of MyOne Streptavidin C1 Dynabeads (Invitrogen/Life
Technologies, USA) were used. Dynabeads were washed with water and equilibrated
twice with 1ml of elution buffer. The 5ml elution from HisBind Fractogel was added
to the beads and incubated on a rotator for 2 h at 4 C. Dynabeads were washed three
times with 2ml Tris binding buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 5%
[v/v] glycerol, 1mM b-mercaptoethanol, 0.2% [v/v] Triton X-100), then three times
with 2ml of TEV cleavage buffer (25mM Tris-HCl pH 8.0, 150mMNaCl, 0.1% [v/v]
Triton X-100, 0.5mM EDTA, 1mm DTT). Beads were resuspended in 500ml of TEV
cleavage buffer, and 500 units of AcTEV protease (Invitrogen/Life Technologies,
USA) was added. The cleavage reaction was left overnight at 4 C. TEV cleavage
product was recovered from the beads and concentrated using TCA precipitation.
The protein pellet was resuspended in 30ml 1 Laemmli sample buffer before
SDS–PAGE and Coomassie staining.
Anti-GFP immunoprecipitation of Mto2[17A]-GFP before SILAC MS analysis
was performed using approximately 35 g each of ‘light’ and ‘heavy’ cell powder.
Lysis buffer (25mM sodium phosphate pH 7.5, 100mM KCl, 0.5mM EDTA, 0.2%
Triton X-100, 10 mgml 1 each of ‘CLAAPE’ protease inhibitors, 2mM AEBSF,
2mM benzamidine and 2mM PMSF), and phosphatase inhibitors (50mM Na
b-glycerophosphate, 1mM NaF, 0.1mM Na3VO4, 50 nM calyculin A and 50 nM
okadaic acid) were added to the cell powder at a ratio of 2ml buffer per 1 g cell
powder, which produced B50ml of extract (protein concentration 12mgml 1).
The solution was kept on ice until fully resuspended. Cell extracts were cleared by
2 15min centrifugation at 4,000g in a Beckman Avanti J-26 centrifuge using a
JLA 8.1000 rotor. For immunoprecipitation, each 1ml of extract was incubated
with 3 107 Protein G Dynabeads, previously covalently coupled to 1.2 mg of
homemade afﬁnity-puriﬁed sheep anti-GFP antibody using dimethyl pimelimidate.
Beads were incubated with the lysate for 90min at 4 C, and then washed six times
with the lysis buffer. Protein was eluted from beads by 15min incubation at 50 C
in Laemmli sample buffer, resolved on 10% SDS–PAGE gel and Coomassie stained.
For Phos-tag SDS–PAGE analysis of phosphatase-treated and untreated GFP-
tagged Mto2-phosphomutant protein, 5 g of cell powder was used for each strain.
Cell extracts were prepared and incubated with anti-GFP beads exactly as for anti-
GFP immunoprecipitations, with the exception that lysis buffer (which included
phosphatase inhibitors) was added to cell powder at a ratio of 1ml buffer per 1 g
cell powder. After 30min incubation at 4 C, beads were washed four times with
lysis buffer, resuspended in 1mL of lysis buffer without phosphatase inhibitors, and
split into two aliquots. For one aliquot, the bound protein was immediately eluted
from beads by 15min incubation at 50 C in Laemmli sample buffer. The other
aliquot was subjected to Lambda phosphatase (NEB) treatment as follows: The lysis
buffer (without phosphatase inhibitors) was removed and the beads were
resuspended in 50 ml of phosphatase buffer (50mM HEPES pH 7.5, 10mM NaCl,
2mM DTT, 0.01% Brij 35) supplemented with 1mM MnCl2, and incubated with
shaking at 30 C overnight. Beads were then washed and the protein eluted by
15min incubation at 50 C in Laemmli sample buffer. In Phos-tag SDS–PAGE, the
following concentrations were used in the resolving gel: 375mM Tris-HCl pH 8.8,
6% acrylamide-bisacrylamide (37.5:1 ratio), 0.1% SDS, 0.1425% APS, 0.275%
TEMED, 10mM Phos-tag-acrylamide (Wako Chemicals) and 100mM MnCl2. To
monitor the progress of electrophoresis, Precision Plus Protein Prestained
Standards (Biorad) were used, supplemented with 7.5mM MnCl2. Following
electrophoresis, the gel was washed for 15min in 100ml of transfer buffer (10mM
CAPS pH 11.0, 10% methanol) supplemented with 1mM EDTA, followed by a
15min wash in transfer buffer without EDTA, and proteins were then wet-
transferred to nitrocellulose membrane.
Mto1-SZZ pulldowns (except those involving G2/M arrest-and-release) were
performed using 1–2 g of cell powder. Cell extracts were prepared exactly as for
anti-GFP immunoprecipitations. For pulldowns, each 1ml of extract was incubated
with 5 106 Dynabeads M270 Epoxy (Invitrogen/Life Technologies), previously
covalently coupled to rabbit IgG (Sigma). Extracts were incubated with beads for
90min at 4 C, and then washed six times with lysis buffer. Protein was eluted from
beads by 15min incubation at 50 C in Laemmli sample buffer, resolved on 10%
SDS–PAGE gel and transferred onto a nitrocellulose membrane.
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For Mto1-SZZ pulldowns after G2/M arrest-and-release, 2 l of cells were grown
in a water-bath at 25 C overnight to OD 0.2 in YE5S. Cultures were then split into
seven ﬂasks; each ﬂask contained 250ml of culture, a volume corresponding to two
time points. One ﬂask was kept at 25 C (‘cycling’), while the other six were shifted
to 36 C (in water-bath) and grown for 3 h 30min. Cultures were then returned to
25 C by brief incubation in ice-water slurry, taking care that temperature during
cooling did not fall below 25 C, and then maintained at 25 C in a water-bath for
time-point sampling. Successive time points were taken every 15min for 225min.
At each time point, 125ml of culture was collected by centrifugation for 1min 30 s
at 3,500g at 4 C in Megafuge 40R (Thermo Scientiﬁc) and washed with 125ml ice-
cold STOP buffer (25mM sodium phosphate pH 7.5, 150mM NaCl, 50mM NaF,
10mM EDTA, 1mM NaN3). Following centrifugation (1min 30 s at 3,500 g at
4 C, Megafuge 40 R (Thermo Scientiﬁc)) cells were resuspended in 1ml (time
points 1–7) or 1.5ml (time points 8–15) of lysis buffer (25mM sodium phosphate
buffer pH 7.5, 100mM KCl, 0.5mM EDTA pH¼ 8.0, 0.2% TritonX-100,
10mgml 1 CLAAPE, 2mM AEBSF, 2mM benzamidine, 2mM PMSF, 50mM Na
b-glycerophosphate, 1mM NaF, 0.1mM Na3VO4, 50 nM calyculin A and 50 nM
okadaic acid). The resulting cell suspension was split into two (time points 1–7) or
three (time points 8–15) screw cap microfuge tubes, the cap was replaced and the
tubes were centrifuged in Biofuge Pico (Heraeus) at 16,000g for 30 s at room
temperature. The supernatant was discarded and the pellet snap frozen in liquid
nitrogen. One tube of each sample was used for each pulldown. Before pulldown,
0.2ml of lysis buffer and 1.2ml of 0.5mm zirconium beads (BioSpec Products)
were added to frozen cell pellets, which were then disrupted by bead-beating using
a Ribolyser (Hybaid), with intermittent cooling (1 60 s, 3 20 s at a speed of 4.0,
with cooling on metal rack at dry ice temperature between each beating cycle).
Another 0.2ml of lysis buffer was added; the suspension was mixed and the extract
was recovered and processed as above for normal Mto1-SZZ pulldowns.
For scoring septation index in these experiments, 500 ml aliquots were taken at
each time point. Cells were centrifuged in a microfuge (Heraeus) at 16,000g for 30 s
at room temperature, and the supernatant was discarded. The pellet was
resuspended in ice-cold MeOH and kept at  20 C. An amount of 5 mL of cell
suspension was incubated with 5 mL Calcoﬂuor White M2R (0.1% ﬂuorescent
brightener 28 (F3543, Sigma), 10mM Tris-HCl pH 7.5) for 5min at room
temperature. 5 mL of cell suspension were then placed on a microscope slide and
examined under a wide-ﬁeld microscope using a DAPI ﬁlter set. Two hundred cells
were scored and the percentage of cells containing a septum was calculated for each
time point.
Western blots of cell extracts and immunoprecipitates were probed with sheep
anti-Mto1 antiserum28, sheep anti-Mto2 antiserum29 and GTU-88 mouse
monoclonal anti-g-tubulin antibody (Sigma, T6557), all at 1:1,000 dilution. Anti-
Mto1 and anti-Mto2 blots were further incubated with unlabelled GT-34 mouse
monoclonal anti-goat antibody (Sigma, G2904), at 1:30,000 dilution, to amplify the
signal, and all blots were probed with IRDye800CW donkey anti-mouse antibody
(Licor, 926-32212), at 1:10,000 dilution. Blots were imaged using an Odyssey
ﬂuorescence imager (Licor) and quantiﬁed using Image Studio (Licor).
For quantiﬁcation of relative Mto2 expression levels in cdc25-22 after release
from G2/M arrest (Fig. 2b), the Mto2 signal in each western blot lane was divided
by the Mto1 signal in the same lane, and these values were normalized to the value
for interphase cycling cells (ﬁrst lane, set to 100).
For quantiﬁcation of expression levels of phosphomutant and phosphomimetic
Mto2 relative to wild-type Mto2 (Figs 3b and 5b,d, Supplementary Fig. 8a), the
Mto2 signal in each Western blot lane was divided by the signal of a nonspeciﬁc
band in the same lane (as loading control), and these values were normalized to the
value for wild-type interphase cells.
For quantiﬁcation of wild-type, phosphomutant and phosphomimetic Mto2
and Gtb1 (g-tubulin) in Mto1-SZZ IgG pulldowns (Figs 2a,b, 4a and 5c,
Supplementary Fig. 8a), Mto2 (wild-type and mutant) and Gtb1 signals in each
western blot lane were divided by the Mto1 pulldown signal in the corresponding
lane, and these values were normalized to the values obtained for interphase wild-
type (mto2þ ) cells, as indicated.
Mass spectrometry analysis. For sample preparation prior to MS analysis,
protein bands of Mto2 or Mto2[17A]-GFP were excised from a Coomassie-stained
gel. The protein was reduced, alkylated and digested with trypsin following stan-
dard procedures67. Digested peptides were desalted using C18 StageTips68. In
SILAC experiments, interphase and mitotic samples were combined after elution
from C18 StageTips.
For MS analysis after Mto2-HTB puriﬁcation, an LTQ-Orbitrap mass
spectrometer (ThermoElectron) was coupled online to an Agilent 1100 binary
nanopump and an HTC PAL autosampler (CTC Analytics). To prepare an
analytical column with a self-assembled particle frit69, C18 material (ReproSil-Pur
C18-AQ 3 mm, Dr Maisch, GmbH) was packed into a spray emitter (75-mm inner
diameter, 8-mm opening, 250-mm length; New Objectives) using an air pressure
pump (Proxeon Biosystems). Mobile phase A consisted of water, 5% acetonitrile,
and 0.5% acetic acid. Mobile phase B consisted of acetonitrile and 0.5% acetic acid.
Peptides were loaded onto the column at a ﬂow rate of 0.7 ml min 1 and eluted at a
ﬂow rate of 0.3 ml min 1. For a 2-h gradient run, elution used a gradient from 0 to
20% B over 75min and then from 20 to 80% B over 13min. Fourier transform
mass spectrometry spectra were recorded at 30,000 resolution, and the six most
intense peaks of the MS scan were selected in the ion trap for fragmentation
(normal scan; wideband activation; ﬁlling, 7.5 105 ions for MS scan and 1.5 104
ions for tandem mass spectrometry (MS/MS); maximum ﬁll time, 150ms). The
dynamic exclusion time was set to 60 s.
For MS analysis after Mto2[17A]-GFP puriﬁcation, peptides were analysed on
Q-Exactive mass spectrometer (Thermo Fisher Scientiﬁc) coupled with a Dionex
Ultimate 3,000 RSLC nano system. A column with a spray emitter (75-mm inner
diameter, 8-mm opening, 250-mm length; New Objectives) was packed with C18
material (ReproSil-Pur C18-AQ 3 mm; Dr Maisch GmbH, Ammerbuch-Entringen,
Germany) using an air pressure pump (Proxeon Biosystems)69. Mobile phase A
consisted of water and 0.1% formic acid. Mobile phase B consisted of 80% ACN
acetonitrile and 0.1% formic acid. Peptides were loaded onto the column with 2% B
at 500 nlmin 1 ﬂow rate and eluted at 200 nlmin 1 ﬂow rate with two gradients:
linear increase from 2 to 40% B in 79min; then increase from 40 to 95% B in
11min. The eluted peptides were directly sprayed into the mass spectrometer.
Full MS Scans were acquired on the Q-Exactive mass analyser over the range
m/z 300–1,750 with a mass resolution of 70,000 (at m/z 200). The target value was
1.0Eþ 06. The 10 most intense peaks with charge stateZ2 were fragmented in the
HCD collision cell with normalized collision energy of 25%, and MS/MS spectra
were with a mass resolution of 35,000 at m/z 200. The target value was 5.0Eþ 05.
The ion selection threshold was 2.1Eþ 04 counts, and the maximum allowed ion
accumulation times were 20ms for full MS scans and 120ms for MS/MS spectra.
The dynamic exclusion time was set to 45 s and repeat count equal to 1.
Mass spectrometric raw ﬁles from experiments on Mto2-HTB were processed
using Mascot (version 2.4.1). Searches were conducted against SwissProt database
(version 2013_07) with taxonomy ﬁlter set to Schizosaccharomyces pombe. The
search parameters were: MS accuracy, 6 p.p.m.; MS/MS tolerance, 0.6Da;
signiﬁcance threshold: 0.05; ﬁxed modiﬁcations, cysteine carbamidomethylation;
variable modiﬁcations, methionine oxidation, serine, threonine and tyrosine
phosphorylation; enzyme, trypsin; maximal allowed number of missed cleavages, 2.
Posterior error probability of the weakest match that was accepted after manual
interrogation was PEP¼ 0.012 (Mascot score 20.82, delta score 3.4).
Mass spectrometric raw ﬁles from analyses of Mto2[17A]-GFP were processed
using MaxQuant (version 1.2.2.5)70. Searches were conducted against an
Mto2[17A]-GFP sequence generated manually. The search parameters were:
MS accuracy, 20 p.p.m.; MS/MS tolerance, 0.5Da; ﬁxed modiﬁcation, cysteine
carbamidomethylation; variable modiﬁcations, methionine oxidation, N-acetylation
of protein N-terminus, serine, threonine and tyrosine phosphorylation; enzyme,
trypsin; maximal allowed number of missed cleavages, 2; labelling amino-acids,
arginine (Arg6) and lysine (Lys8). FDR was set to 1 as the data set was considered
being too small for meaningful FDR estimation using the target-decoy method.
Mto2 hits were manually validated, the weakest having a posterior error probability
of PEP¼ 0.013.
XiSPEC Spectrum Viewer (http://spectrumviewer.org/) was used to visualize
MS2 spectra for ﬁgure presentation.
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